手持设备房颤筛查方案依从性与临床结局的关联
在STROKESTOP和STROKESTOP II两项系统房颤筛查项目中,评估手持心电图设备筛查方案的依从性及依从一致性及其与不良脑心血管结局的关联。STROKESTOP要求每日两次30秒测量持续2周,STROKESTOP II要求每日四次持续2周。STROKESTOP依从性中位数100%(92-100%),依从一致性中位数12天(11-13);STROKESTOP II分别为90%(75-98%)和8天(3-11)。低依从性和依从一致性与不良脑心血管结局风险升高相关。
要点
- 每日两次手持心电图测量(STROKESTOP)的依从性高于每日四次(STROKESTOP II)。
- 女性和较低教育程度与更优依从性及依从一致性相关。
- 低依从性和依从一致性与不良脑心血管结局风险升高相关。
核心结论
- STROKESTOP中每日两次手持心电图测量的依从性高于STROKESTOP II中每日四次测量。
- 女性和较低教育程度与≥100%依从性和依从一致性相关。
- 低依从性和依从一致性与不良脑心血管结局风险升高相关。
研究设计与样本
- 基于STROKESTOP(2012年)和STROKESTOP II(2016年)两项系统房颤筛查项目的事后分析。
- 纳入STROKESTOP 6436名参与者(55.7%女性)和STROKESTOP II 3712名参与者(59.8%女性)。
- STROKESTOP要求每日两次30秒测量持续2周,STROKESTOP II要求每日四次持续2周。
- 依从性定义为完成测量次数除以要求测量次数,依从一致性定义为完整记录的天数。
主要发现
- STROKESTOP依从性中位数100%(92-100%),依从一致性中位数12天(11-13)。
- STROKESTOP II依从性中位数90%(75-98%),依从一致性中位数8天(3-11)。
临床怎么用
- 在房颤筛查中可采用每日两次手持心电图测量方案以提高依从性。
- 对依从性低的参与者应关注其不良脑心血管结局风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate adherence and adherence consistency to the handheld ECG device-based screening protocol and their association with adverse cerebral and cardiovascular outcomes in two systematic atrial fibrillation (AF) screening programmes. METHODS: In 2012 (Systematic ECG Screening for Atrial Fibrillation Among 75-Year Old Subjects in the Region of Stockholm and Halland, Sweden (STROKESTOP) study) and 2016 (Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide (STROKESTOP II) study), half of all 75- and 76-year-old inhabitants of up to two Swedish regions were invited to participate in a systematic AF screening programme. Participants were instructed to perform 30-second measurements twice daily in STROKESTOP and four times daily in STROKESTOP II for 2 weeks. Adherence was defined as the number of measurements performed divided by the number of measurements asked, whereas adherence consistency was defined as the number of days with complete registrations. RESULTS: In total, 6436 participants (55.7% female) from STROKESTOP and 3712 (59.8% female) from STROKESTOP II were included. Median adherence and adherence consistency were 100 (92-100)% and 12 (11-13) days in STROKESTOP and 90 (75-98)% and 8 (3-11) days in STROKESTOP II. Female sex and lower education were factors associated with both optimal adherence and adherence consistency in both studies. In STROKESTOP, low adherence and adherence consistency were associated with higher risk of adverse cerebral and cardiovascular outcomes (HR for composite primary endpoint 1.30 (1.11 to 1.51), p=0.001), including stroke (HR 1.68 (1.22 to 2.32), p=0.001) and dementia (1.67 (1.27 to 2.19), p<0.001). CONCLUSIONS: Adherence to twice daily handheld ECG measurements in STROKESTOP was higher than to four times daily measurements in STROKESTOP II. Female sex and lower educational attainment were associated with ≥100% adherence and adherence consistency. Low adherence and adherence consistency were associated with a higher risk of adverse outcomes.
引用
- van der Velden, Bonander, Crijns, et al. Adherence to a handheld device-based atrial fibrillation screening protocol is associated with clinical outcomes. Heart. 2024. PMID: 38182278. doi:10.1136/heartjnl-2023-323522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。